ArticleBMJ open2025

Multicentre, multi-arm, double-blind randomised placebo-controlled dose-finding trial investigating the safety and Efficacy of MirococePt (APT070) In Reducing delayed graft function In the Kidney ALlograft (EMPIRIKAL-2): study protocol for a randomised controlled trial.

Theodoros Kassimatis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.